Benzimidazoles
Cayman Chemical Omeprazole-d3 1mg
An internal standard for the quantification of omeprazole by GC- or LC-MS
Medchemexpress LLC Omeprazole | 73590-58-6 | 100.0% | C17H19N3O3S | 25 G
Omeprazole is a proton pump inhibitor (PPI) used for treating acid-related gastrointestinal disorders, including dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger-Ellison syndrome.
- Used for treating acid-related gastrointestinal disorders
- Competitively inhibits CYP2C19 activity with a Ki of 2 to 6 μM
- Inhibits the growth of both Gram-positive and Gram-negative bacteria
- Potent brain-penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)
Medchemexpress LLC Omeprazole sulfone | 88546-55-8 | 99.23% | 361.42 | 5 MG
Omeprazole sulfone is one of the major metabolites of Omeprazole (HY-B0113). It is generated via sulfoxidation mediated by cytochrome P450 3A4 (CYP3A4).
- For research use only.
- Not sold to patients.
Medchemexpress LLC Omeprazole-d3 | 922731-01-9 | 99.0% | 348.43 g/mol | C17H16D3N3O3S | 10 MG
Omeprazole-d3 is a deuterium-labeled omeprazole supplied as a stable-isotope reference standard for analytical and research applications, especially as an internal standard in LC-MS, pharmacokinetic, and metabolic studies. It is provided as a light brown solid with high chemical purity suitable for quantitative analysis.
- Deuterium-labeled internal standard for LC-MS quantitation.
- High chemical purity (≈99.0%) suitable for analytical applications.
- Solid form with light brown to brown appearance for easy handling.
- Includes CAS number 922731-01-9 for unambiguous identification.
- Stable when stored as powder at -20°C for up to 3 years.
Med Vet International Omeprazole Delayed Release Capsules, 20mg, 30ct.
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
Omeprazole is a proton pump inhibitor that helps decrease the amount of acid produced in the stomach.
Cayman Chemical Omeprazole-d3 500ug
An internal standard for the quantification of omeprazole by GC- or LC-MS
Cayman Chemical 4-desmethoxy Omeprazole 10mg
A potential impurity found in commercial omeprazole and esomeprazole magnesium preparations
Medchemexpress LLC (R)-Omeprazole sodium | 161796-77-6 | 98.1% | 50 MG
(R)-Omeprazole sodium is a gastric acid resistant compound that inhibits gastric acid secretion. Its metabolism in vivo is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. It exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.
- Gastric acid resistant compound
- Inhibits gastric acid secretion
- Metabolized primarily by cytochrome P450 enzymes
- Interaction with mannitol may affect bioavailability
- Exhibits reversible direct and metabolism-dependent inhibition of CYP2C19
Medchemexpress LLC (R)-Omeprazole (sodium) | 161796-77-6 | 98.1% | 250 MG
(R)-Omeprazole sodium is a gastric acid resistant compound that inhibits gastric acid secretion. It is primarily metabolized in vivo by cytochrome P450 enzymes. Interactions with mannitol may affect its bioavailability in certain formulations.
- Inhibits gastric acid secretion
- Metabolized by cytochrome P450 enzymes
- Interacts with mannitol
- Reversibly inhibits CYP2C19 directly and metabolism-dependently
- For research use only
Medchemexpress LLC (R)-Omeprazole (sodium) | 161796-77-6 | 98.1% | 25 MG
(R)-Omeprazole sodium is a gastric acid resistant compound that inhibits gastric acid secretion. It is metabolized in vivo, primarily by cytochrome P450 enzymes, and its interaction with mannitol may affect its bioavailability in formulations. It exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.
- Gastric acid resistant compound
- Inhibits gastric acid secretion
- Metabolized by cytochrome P450 enzymes
- Reversible direct and metabolism-dependent inhibition of CYP2C19
- For research use only
Medchemexpress LLC Omeprazole sulfide-d3 | 922730-98-1 | MFCD09841123 | 99.8% | C17H16D3N3O2S | 10MG
Omeprazole sulfide-d3 is the deuterium-labeled analogue of omeprazole sulfide, supplied as a stable isotope reference standard for analytical and metabolic studies. It is intended for use as an internal standard in quantitative mass spectrometry and pharmacokinetic investigations.
- Deuterium-labeled internal standard for LC-MS quantitation.
- High purity (99.8%).
- Suitable for metabolic and pharmacokinetic studies.
- Small package sizes convenient for analytical workflows.
- Stable as a powder at -20 °C for long-term storage; follow solvent storage recommendations.
- Handling notes: hygroscopic DMSO affects solubility; aliquot and avoid repeated freeze-thaw.
Apexbio Technology LLC Albendazole Oxide 54029-12-8 10mM (in 1mL DMSO)
Albendazole Oxide (CAS 54029-12-8) is a small-molecule inhibitor targeting beta-tubulin It is designed to inhibit beta-tubulin polymerization in parasites thereby disrupting cytoplasmic microtubule structure and interfering with glucose metabolic pathways Albendazole Oxide exerts its biological activity primarily through inhibition of beta-tubulin polymerization In both in vitro and in vivo studies Albendazole Oxide demonstrates anti-parasitic activity with reported IC50 values typically ranging from nanomolar to micromolar concentrations depending on the parasite species and assay system Based on these pharmacological properties Albendazole Oxide holds research potential in the exploration of anti-parasitic pharmacodynamics notably for studies involving Echinococcus spp and other parasitic infections
Medchemexpress LLC Fenbendazole (Standard) | 43210-67-9 | 99.9% | 50 MG
Fenbendazole (Standard) | 43210-67-9 | 99.9% | 50 MG
Cayman Chemical Albendazole sulfon 25mg
An active metabolite of albendazole; inhibits spore formation of E. hellem, E. cuniculi, and E. intestinalis in vitro (IC90s = <0.0001, <0.001, and <0.1 UG/ml, respectively)